Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 6,500 shares at $12.01 ($78K) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Open-market sale of $78k JNCE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JNCE | SELL | 2021-03-31 | $136K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $36K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |